Suppr超能文献

加拿大实际应用中对西地那非的治疗满意度。一项针对基层医疗实践的为期6个月的前瞻性观察研究。

Treatment satisfaction with sildenafil in a Canadian real-life setting. A 6-month prospective observational study of primary care practices.

作者信息

Carrier Serge, Brock Gerald, Casey Richard, Tarride Jean-Eric, Elliott Stacey, Dugré Hélène, Rousseau Catherine, D'Angelo Pina, Defoy Isabelle

机构信息

McGill University Health Center, Montreal, Canada.

出版信息

J Sex Med. 2007 Sep;4(5):1414-21. doi: 10.1111/j.1743-6109.2007.00555.x. Epub 2007 Jul 21.

Abstract

INTRODUCTION

While the efficacy of sildenafil for the management of erectile dysfunction (ED) has been demonstrated in randomized clinical trials, few data exist on its effectiveness in a real-life setting.

AIM

The objective of this study was to examine the treatment satisfaction and effectiveness with sildenafil in a real-life setting in Canada.

METHODS

A multicenter, prospective study, using an educational program aimed at optimizing sildenafil treatment, was conducted at 231 primary care sites across Canada. Patients who received their first prescription of sildenafil for ED within the usual practice of medicine were invited to participate in the study. Data were collected through patient self-administered questionnaires.

MAIN OUTCOME MEASURES

The Sexual Health Inventory for Men (SHIM) questionnaire was used to determine the erectile function at baseline, month 3 and month 6. Treatment satisfaction at months 3 and 6 was assessed using the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire.

RESULTS

The intent-to-treat population consisted of 2,573 patients. The mean age was 55 years (18 to 92 years). At baseline, the mean SHIM score was 11.9 with 21.7% of men having severe ED, 22.9% moderate ED, 36.5% mild-to-moderate ED, and 16.9% mild ED. At month 3, the mean SHIM score improved significantly to 18.0 (P < 0.0001) and 33.3% of patients had a SHIM score above 21 (no ED). At 6 months, the mean SHIM score was 18.7. At both months 3 and 6, approximately 89% of patients were satisfied with their treatment (i.e., EDITS score >or= 50), suggesting no attenuation of the satisfaction over the 6 months of use.

CONCLUSIONS

The effectiveness of sildenafil in the management of ED was demonstrated in a large cohort of men treated in a primary care setting in this Canadian real-life study. Persistence with therapy and lack of attenuation over time among the vast majority of men was shown.

摘要

引言

虽然随机临床试验已证明西地那非治疗勃起功能障碍(ED)的疗效,但关于其在现实生活中的有效性的数据却很少。

目的

本研究的目的是在加拿大的现实生活环境中检验西地那非的治疗满意度和有效性。

方法

在加拿大全国231个初级保健机构开展了一项多中心前瞻性研究,采用旨在优化西地那非治疗的教育项目。邀请在常规医疗实践中首次接受西地那非治疗ED处方的患者参与研究。通过患者自行填写问卷收集数据。

主要观察指标

使用男性性健康量表(SHIM)问卷来确定基线、第3个月和第6个月时的勃起功能。使用治疗满意度勃起功能障碍量表(EDITS)问卷评估第3个月和第6个月时的治疗满意度。

结果

意向性分析人群包括2573例患者。平均年龄为55岁(18至92岁)。基线时,平均SHIM评分为11.9,重度ED患者占21.7%,中度ED患者占22.9%,轻度至中度ED患者占36.5%,轻度ED患者占16.9%。在第3个月时,平均SHIM评分显著提高至18.0(P<0.0001),33.3%的患者SHIM评分高于21(无ED)。在6个月时,平均SHIM评分为18.7。在第3个月和第6个月时,约89%的患者对治疗感到满意(即EDITS评分≥50),表明在6个月的使用期内满意度没有下降。

结论

在这项加拿大现实生活研究中,一大群在初级保健机构接受治疗的男性中证明了西地那非治疗ED的有效性。绝大多数男性表现出持续治疗且随着时间推移满意度未下降。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验